study_id,year,design,effect_type,effect_point,ci_low,ci_high,n_treat,n_ctrl,risk_of_bias,doi,journal_id,outcome,population,adverse_events,duration_weeks
COG-CAFF-ADJ_01,2011,randomized controlled trial,SMD,0.3084,0.1568,0.4600,56,48,low,10.1016/j.biopsycho.2007.09.008,cognition_journal,attention,Adults with attention concerns,None reported,6
COG-CAFF-ADJ_02,2012,randomized controlled trial,SMD,0.3450,0.2133,0.4767,60,51,some concerns,10.1179/147683008X301513,cognition_journal,attention,Adults with attention concerns,Mild GI discomfort,7
COG-CAFF-ADJ_03,2013,randomized controlled trial,SMD,0.4243,0.2688,0.5798,64,54,mixed,10.1007/s00213-015-3895-0,cognition_journal,attention,Adults with attention concerns,Transient headache,8
